Liver Diseases: all 2,094 studies
Page 18 of 21. Open to participants first (390), then studies with results posted, then the rest; newest registration first within each.
- Safety Pilot Study of Farnesoid X Receptor (FXR) Agonist in Non-alcoholic Fatty Liver Disease (NAFLD) PatientsCompletedNCT01999101Phase 2
- Association of Non-alcoholic Fatty Liver Disease and Diabetes MellitusCompletedNCT01997424Not applicable
- A Study in Cancer Patients With Hepatic Impairment to Evaluate the Pharmacokinetics and Safety of NKTR-102 (Etirinotecan Pegol)CompletedNCT01991678Phase 1
- Non-invasive Biomarkers of Fibrosis in Pediatric Liver DiseasesCompletedNCT01988753
- Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin TreatmentWithdrawnNCT01987310Not applicable
- Prospective, Cross-sectional and Multicenter Study, Evaluating the Diagnosis Accuracy of the Controlled Attenuation Parameter(CAP) Measured by FibroScan® (Either With M+ or XL+ Probe) in Patient With Non-Alcoholic Fatty Liver Disease Using Liver Biopsy as Reference.CompletedNCT01985009Not applicable
- EVP-6124 Hepatic Impairment StudyCompletedNCT01984736Phase 1
- Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve PatientsCompletedNCT01970904Not applicable
- Pharmacokinetics of Caspofungin After One Dose in Patients With Liver FailureCompletedNCT01968395Phase 4
- Genetics of Fatty Liver Disease in ChildrenCompletedNCT01966627
- Correlation Between NAFLD, Epicardial Adipose Tissue and Vascular Inflammation Measured by Positron Emission Tomography (PET) With 18F-fluoro-deoxyglucose (FDG)CompletedNCT01958411
- Study Comparing in Livertransplantation Recipients With Tacrolimus Alone Versus Tacrolimus&SirolimusCompletedNCT01958190Phase 4
- The Effect Of Dual Treatment With L-Carnitine And Magnesium On Fatty LiverStatus unknownNCT01956825Phase 4
- Effect of Hepatic Impairment on LDK378 PharmacokineticsCompletedNCT01950481Phase 1
- Evaluation of Sickle Cell Liver DiseaseCompletedNCT01950429
- Real Time Elastography in Liver FibrosisStatus unknownNCT01948687
- Purified Anthocyanin and Nonalcoholic Fatty Liver DiseaseCompletedNCT01940263Early Phase 1
- Efficacy and Tolerance of Treatment With DHA, Choline and Vitamin E in Children With Non-alcoholic SteatohepatitisCompletedNCT01934777Phase 3
- Antinociceptive Modalities on Ischemia Reperfusion InjuryCompletedNCT01932918
- LIVER FIBROSIS PREVALENCE IN FRANCEStatus unknownNCT01927133
- Nutrition and Pregnancy Intervention StudyCompletedNCT01922791Not applicable
- Risk of Methicillin-resistant S.Aureus (MRSA) Infections in MRSA Carrier Under Introduction of Rapid MRSA ScreeningCompletedNCT01918813Not applicable
- Hepatic Impairment Trial of Obeticholic AcidCompletedNCT01904539Phase 1
- Improvement of Transient Elastography Applicability and Diagnostic Accuracy to Identify Significant Fibrosis by Experienced Operators Using the M and XL Probe.CompletedNCT01900808
- Mediterranean Lifestyle Intervention in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT01894438Not applicable
- Evaluation of Liver Disease With Elastography Measurements in Patients Undergoing Liver Transplant SurgeryCompletedNCT01890460
- Study of Lumacaftor in Combination With Ivacaftor in Subjects With Moderate Hepatic Impairment and Healthy SubjectsCompletedNCT01888393Phase 1
- The Effect of Helicobacter Pylori Eradication on Liver Fat Content in Non-alcoholic Fatty Liver DiseaseCompletedNCT01876108Phase 2
- Non Invasive Assessment of Liver Fibrosis in Fatty Liver DiseaseCompletedNCT01874249Not applicable
- The Physiology of Fatigue in Patients With Chronic Liver DiseaseCompletedNCT01867385
- A Study to Evaluate the Pharmacokinetics of JNJ-38518168 in Patients With Mild and Moderate Hepatic Impairment Compared With Patients With Normal Hepatic FunctionCompletedNCT01863784Phase 1
- Intestinal Microbiota and NAFLD Pre and Post Bariatric SurgeryStatus unknownNCT01856465
- The Role of Non-Alcoholic Fatty Liver Disease in Gestational DiabetesTerminatedNCT01855386
- MBT Versus HVPG in Identifying Responders to Portal Hypertension TherapyCompletedNCT01851252Phase 1
- Evaluating the Efficacy of CPAP Therapy for the Treatment of Fatty LiverWithdrawnNCT01849081Not applicable
- Use of Indocyanine Green Cholangiography and Methylene Blue to Detect Postoperative Biliary Fistula After HepatectomyCompletedNCT01847612Phase 3
- Factors Associated With End Stage Liver DiseaseTerminatedNCT01846819
- The Effect of Exercise Intervention on Insulin Resistance in Non-alcoholic Fatty Liver Disease (NAFLD)CompletedNCT01834300Not applicable
- Efficacy and Safety Study of TUDCA Compare UDCA to Treatment Chronic Cholestatic Liver Disease-PBCCompletedNCT01829698Phase 3
- Impact of Bariatric Surgery on Nonalcoholic Fatty Liver DiseaseCompletedNCT01828528
- Stratification of Patients With Chronic Liver Disease Using Multi Spectral CTCompletedNCT01825213
- Alcohol Biomarkers in Post-Liver Transplant PatientsCompletedNCT01812226
- Pre-recovery Bedside Liver Biopsy in Brain Death Organ DonorsTerminatedNCT01810640Not applicable
- Myfortic in High MELD Liver TransplantationWithdrawnNCT01807767Not applicable
- Pilot-study: Non-thermal Ablation Using Irreversible Electroporation to Treat Colorectal Liver MetastasesCompletedNCT01799044Phase 1
- Effect of Mediterranean Diet on Non-alcoholic Fatty Liver DiseaseCompletedNCT01798719Not applicable
- Study of Peripheral Tissue Oxygenation in End-stage Liver Disease Patients During Liver TransplantationWithdrawnNCT01794637
- Novel Association of Cholesterol Ester Storage Disease Due to Lysosomal Acid Lipase Deficiency and Non-Alcoholic Fatty Liver Disease: A Prospective Clinical StudyStatus unknownNCT01791452
- An Open-label, Single-dose, Intravenous Administration Study of ONO-2745/CNS 7056 in Subjects With Chronic Hepatic ImpairmentCompletedNCT01790607Phase 1
- Transient Elastography in the Determination of Advanced Fibrosis in Alcoholic Liver Disease.CompletedNCT01789008Not applicable
- A Study to Evaluate the Pharmacokinetics of PCI-32765 in Participants With Varying Degrees of Hepatic ImpairmentCompletedNCT01767948Phase 1
- Altered Drug Disposition and Biomarkers for Diagnosis of Chronic Inflammatory Liver DiseaseCompletedNCT01766960Phase 1
- Randomized Controlled Trial of ImmuKnow in Liver TransplantationCompletedNCT01764581Not applicable
- Open Label Pharmacokinetic Study of SAR302503 in Subjects With Hepatic ImpairmentCompletedNCT01762462Phase 1
- Resting Energy Expenditure in Patients on the Waiting List for Liver TransplantationCompletedNCT01761851
- Study of PD/PK/PG Relationships of Tacrolimus and Cyclosporin in Liver Transplant PatientsTerminatedNCT01760356
- Patterns of Early Hepatitis C Virus Decline Predict the Outcome of Interferon Therapy (sIFN-pred2)Status unknownNCT01760148
- Helicobacter Pylori Eradication in Subjects With Non-alcoholic Fatty Liver DiseaseCompletedNCT01759628Phase 2
- Predicting Lung Injury From Transfusion in Patients With Liver DiseaseTerminatedNCT01756690
- Effects of Vitamin D on Inflammation in Liver DiseaseStatus unknownNCT01754961Phase 2
- Efficacy and Safety of Omega-3 Lipid Therapy in Pediatric Patients With Parenteral Nutrition-Associated Liver DiseaseStatus unknownNCT01739517Phase 2
- THE ASSOCIATION BETWEEN FATTY LIVER (NAFLD) DISEASE AND PCOSStatus unknownNCT01735799
- Safety and Efficacy of Human Umbilical Cord Derived Mesenchymal Stem Cells for Treatment of HBV-related Liver CirrhosisStatus unknownNCT01728727Phase 1/2
- Safety and Efficacy of Human Autologous Peripheral Blood Stem Cells for Treatment of HBV-related Liver CirrhosisStatus unknownNCT01728688Phase 1/2
- Pharmacokinetic Study of BKM120 in Subjects With Hepatic ImpairmentCompletedNCT01727128Phase 1
- Safety and Efficacy of Human Bone Marrow Stem Cells for Treatment of HBV-related Liver CirrhosisStatus unknownNCT01724697Phase 1/2
- Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver DiseaseStatus unknownNCT01720719Phase 4
- Baclofen in the Treatment of Alcohol Dependence With or Without Alcoholic Liver DiseaseCompletedNCT01711125Phase 3
- Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver DiseaseStatus unknownNCT01711073Phase 1
- Clinical Investigation on the Effects of Bayberry Juice Treatment in Adult Subjects With Features of Fatty Liver DiseaseCompletedNCT01707914Not applicable
- Prospective Trial Comparing Conventional Versus Piggyback Method in Venous Drainage of the Transplanted LiverCompletedNCT01707810Not applicable
- Biochemical and Genetic Markers in Liver DiseasesStatus unknownNCT01706614
- Multimodal Approach in IBD PatientsStatus unknownNCT01705522
- Biomarkers for the Prognosis of Decompensated Alcoholic Liver DiseaseCompletedNCT01701687
- Hepar-P Study to Evaluate the Safety and Efficacy of a Standardised Extract of Phyllanthus Niruri for the Treatment of Non-alcoholic Fatty Liver DiseaseStatus unknownNCT01680003Phase 2
- Efficacy and Safety of Modified Anti-tubercular Regimens in Treatment of Tuberculosis in Patients With Underlying Compensated and Decompensated Chronic Liver DiseaseStatus unknownNCT01677871Not applicable
- The Clinical Trail Of NAFLD Treated By Traditional Chinese MedicineCompletedNCT01677325Phase 1
- Glucose-induced Glucagon-like Peptide 1 (GLP-1) Secretion in NAFLD Patients Compared to Healthy ControlsCompletedNCT01674972
- Cardiopulmonary Exercise Testing in Cirrhotic Patients: a Pilot StudyCompletedNCT01658982
- Study of the Association of Nonalcoholic Fatty Liver Disease With Colorectal Malignant NeoplasmCompletedNCT01657773
- Impact of an Antibiotic (Rifaximin) on Liver Scarring in HIV-Infected Patients With Liver DiseaseWithdrawnNCT01654939Phase 4
- Effects of Siliphos-Selenium-Methionine-Alpha Lipoic Acid in Patients With Fatty Liver and Non-alcoholic SteatohepatitisCompletedNCT01650181Phase 4
- A Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver ResectionCompletedNCT01645852Not applicable
- Non-invasive Diagnosis of Portal Hypertension With Acoustic Radiation Force Impulse (ARFI)CompletedNCT01644656Not applicable
- Heritability of Fatty Liver as Measured by MRI: a Cross Sectional Study of Twins and Family MembersStatus unknownNCT01643512
- Association of Non-alcoholic Fatty Liver Disease and Coronary Artery DiseaseStatus unknownNCT01638832Not applicable
- Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver DysfunctionCompletedNCT01638533Phase 1
- Relative-dose-response Test (RDR) Adaptation for Chronic Liver DiseaseCompletedNCT01634698Not applicable
- ST-2; a Non-invasive Fibrosis Marker for Chronic Hepatitis BStatus unknownNCT01633554
- A Single-Dose Study of Tivozanib in Subjects With Hepatic Impairment and Normal Hepatic FunctionCompletedNCT01631097Phase 1
- Genetic Studies of Non-Alcoholic Fatty Liver DiseaseTerminatedNCT01629095
- Effect on Liver Histology of Vitamin D in Patients With Non-alcoholic SteatohepatitisStatus unknownNCT01623024Phase 3
- Adult-to-Adult Living Donor Transplant Cohort StudyCompletedNCT01619475
- Continuous Renal Replacement Therapy in the Setting of Orthotopic Liver TransplantWithdrawnNCT01619449Not applicable
- The Effects of Bariatric Surgeries on Non-Alcoholic Fatty Liver DiseaseStatus unknownNCT01619215
- Sample Size Definition in Cochrane Hepato-Biliary TrialsStatus unknownNCT01604720
- A Study to Assess Safety and Pharmacokinetics of Telaprevir in Patients With Hepatic ImpairmentCompletedNCT01600976Phase 1
- Pharmacokinetics of LCQ908 in Patients With Hepatic ImpairmentCompletedNCT01594957Phase 1
- Evaluation of Mechanisms Responsible for Coma in Patients Affected by Fulminant, Acute and Chronic Hepatic FailureTerminatedNCT01582087
- A Study to Investigate the Effect of Mirabegron (YM178) on Subjects With Mild or Moderate Hepatic Impairment Compared to Healthy SubjectsCompletedNCT01579461Phase 1